()-[1-(cis),3α,4β]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride结构式
|
常用名 | ()-[1-(cis),3α,4β]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride | 英文名 | ()-[1-(cis),3α,4β]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride |
---|---|---|---|---|
CAS号 | 79516-67-9 | 分子量 | 456.980 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C26H30ClFN2O2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | R50547 |
---|---|
英文别名 | 更多 |
分子式 | C26H30ClFN2O2 |
---|---|
分子量 | 456.980 |
精确质量 | 456.197998 |
4-Piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3S,4R)-, hydrochloride (1:1) |
Levocabastine hydrochloride |
(3S,4R)-1-(cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid monohydrochloride |
acide (3S,4R)-1-[cis-4-cyano-4-(4-fluorophényl)cyclohexyl]-3-méthyl-4-phénylpipéridine-4-carboxylique chlorhydrate |
Levocabastine for system suitability 2 |
Levostin |
R50547 |
(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid hydrochloride (1:1) |
[3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid |
Levophta |
(3S,4R)-1-[cis-4-Cyan-4-(4-fluorphenyl)cyclohexyl]-3-methyl-4-phenylpiperidin-4-carbonsäurehydrochlorid |
(3S,4R)-1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride |
4-piperidinecarboxylic acid, 1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-, (3S,4R)-, monohydrochloride |
MFCD07787408 |
(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride (1:1) |
Levocabastine (hydrochloride) |